Preliminary Survey in Preparation for the Implementation of ERAS at Dr Soetomo Hospital

July 17, 2022 updated by: Dr. Anna Surgean Veterini, dr., SpAn., KIC, Dr. Soetomo General Hospital
This study aims to analyze the readiness of the team that will support the ERAS application at Regional General Academic Hospital Dr Soetomo.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This is an observational analytic study with a cross-sectional design using a questionnaire. Patient baseline data were taken from the examination at the anesthesiology outpatient clinic. The patient's level of understanding was assessed by two investigators and rated on a scale of 1 to 5. Primary data and assessment of understanding of doctors and medical personnel were filled in independently by research subjects on online forms and rated on a scale of 1 to 5.

Study Type

Observational

Enrollment (Actual)

207

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Indonesia
    • East Java
      • Surabaya, East Java, Indonesia, 60286
        • Dr Soetomo General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients who come to the anesthesiology polyclinic to prepare for SC surgery, simple urology, and simple orthopaedics.

Description

Inclusion Criteria:

  • Patients with elective cesarean, urology, and simple orthopaedic surgery plans
  • Patient with PS ASA 1-2

Exclusion Criteria:

  • Patients with communication disorders / mental disorders
  • Patients with outpatient surgery plans

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patient
Patient baseline data were taken from the examination at the anesthesiology outpatient clinic. (N=41)
Procedure: ERAS
This study is a cross-sectional observational study by distributing questionnaires regarding the readiness to implement ERAS at Dr Soetomo General Hospital to the subjects, so there is no treatment whatsoever on the subjects.
Doctor
Consists of specialist and resident anesthesiology, orthopaedic surgery and traumatology, obstetrics and gynaecology, urology. (N=110)
Healthcare worker
Consists of nutritionists, pharmacists, surgical nurses, anesthesiologists, and recovery room nurses.(N=56)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of understanding (using questionnaire)
Time Frame: 1 month

This outcome is reported by a score on a scale. The minimum value is one, and the maximum value is five. Higher scores mean better outcomes.

Scale title:

  1. Strongly don't understand
  2. Don't understand
  3. Neutral
  4. Understand
  5. Strongly understand
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Dr. Soetomo General Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 23, 2022

Primary Completion (ACTUAL)

April 14, 2022

Study Completion (ACTUAL)

April 14, 2022

Study Registration Dates

First Submitted

July 12, 2022

First Submitted That Met QC Criteria

July 17, 2022

First Posted (ACTUAL)

July 19, 2022

Study Record Updates

Last Update Posted (ACTUAL)

July 19, 2022

Last Update Submitted That Met QC Criteria

July 17, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 0815/LOE/301.4.2/III/2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD able to be shared with other researchers with permission

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ERAS

Clinical Trials on ERAS

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe